Aging is the single greatest risk factor for many of today’s most devastating conditions, including Alzheimer’s and other neurodegenerative diseases. Yet, for decades, medicine has largely focused on treating symptoms rather than addressing the biological processes that drive decline.

At Biocient, we are studying the underlying mechanisms of aging—such as cellular stress, metabolic dysfunction, and biomarker shifts—we uncover new pathways to intervene earlier and more effectively. This approach does more than extend years of life—it aims to extend quality of life, giving people the possibility of living healthier, longer, and more vibrant lives.

At Biocient, artificial intelligence is integrated as the foundation of our scientific innovation. Leveraging cutting-edge machine learning techniques on disease-specific datasets, we enhance every phase of preclinical research—from target identification and data analysis to outcome prediction and decision optimization. Our AI system enables rapid, accurate insights that reduce risk and drive smarter, more efficient discovery processes. By transforming complex data into strategic intelligence, we deliver unparalleled precision and a decisive competitive edge in biomedical research.

AI-Driven Discovery

The CytoCore Platform underpins our multi-asset pipeline and drives value creation across multiple therapeutic areas. By integrating proprietary bioactive compounds with systems-level insights, CytoCore enables us to develop high-impact interventions targeting neurodegeneration, metabolic dysfunction, vision, inflammation, and more. This unified, multi-pathway approach positions Biocient at the forefront of translational science—powering scalable innovation in the pursuit of healthier, longer lives. Follow our journey as we share our latest discoveries and advancements.

CytoCore Platform

Our research focuses on the intersection of mitochondrial health and neuronal survival, two critical aspects that are often disrupted in conditions such as Alzheimer's, Parkinson's, Huntington’s, glaucoma, and ALS. Our proprietary mechanism aims to restore mitochondrial integrity—the powerhouses of the cell—by modulating key molecular pathways involved in energy metabolism, oxidative stress, and apoptotic signaling. By preserving mitochondrial function, we help sustain neuronal health and resilience, potentially slowing or even reversing neuronal damage.

Main Areas of Research